Ads
related to: prostate+cancer%2C+cell- nmCRPC Treatment Option
31% Risk of Death Decrease
Visit The Patient Site.
- Dosing & Administration
View Recommended Dosage & Learn
About Drug Interactions Here.
- Clinical Information
Read About A Double-Blind, Placebo-
Controlled, Randomized Study.
- Downloadable Resources
Resources For Physicians & Patients
Available On The Site To Download.
- mHSPC Treatment Option
32% Risk of Death Decrease
Visit The Patient Site.
- Patient Profiles
Explore Patient Profiles To Assess
A Treatment Option.
- nmCRPC Treatment Option
Search results
... Clearance from FDA of IND Application for 225Ac-FL-020 for the Treatment of Metastatic...
WROC Rochester· 5 days agoFood and Drug Administration (FDA) for clinical trials of 225Ac-FL-020, its PSMA-targeted...
AI cancer screening programs are booming, but you'll likely have to pay for them yourself
CNBC· 4 days agoThe FDA has approved nearly 600 radiology AI program since 2019, but most aren't covered by Medicare...
'Disturbing' surge in young cancers may be linked to gut health, say experts
Daily Express· 23 hours agoUnhealthy lifestyles, an obesity epidemic and poor gut health are feared to be fuelling a...
Top 10 most common cancers among Blacks
Rolling Out· 5 days agoUnderstanding the most common cancers among African Americans is crucial for improving prevention, early detection, and treatment strategies.
Overlooked lipid connected to ancient cellular pat | Newswise
Newswise· 7 days agoWithin the family of cell membrane lipids known as phosphoinositides and the kinase enzymes that...
New Study Finds Underutilization of Early Palliati | Newswise
Newswise· 3 days agoXin Hu, a visiting scientist with the American Cancer Society, identified patients 65.5 years old and older, newly diagnosed with advanced breast, colorectal, non-small < ...
Cancer can be caused by reversible molecular changes – as new study shows
The Conversation· 6 days agoThis theory posits that DNA mutations are the primary cause of cancers. It’s well known that ageing, as well as some lifestyle and environmental factors (such as smoking and ...
Moffitt Cancer Center Uses AI to Develop More Pers | Newswise
Newswise· 7 days agoConventional treatment strategies, which focus on maximal cell killing, frequently fail against metastatic cancers due to the emergence of drug resistance ...
Newswise Expert | Daniel Petrylak, Yale Cancer Center/Smilow Cancer Hospital
Newswise· 2 days agoDaniel P. Petrylak is a pioneer in the research and development of new drugs and treatments to fight prostate, bladder, kidney and testicular cancer. For ...
Joanina Gicobi's road from rural Kenya to earning her Ph.D. in Rochester came through resilience,...
Post-Bulletin· 6 days ago"I am looking at prostate cancer and the mechanisms of resistance to the standard therapies," Gicobi said. "We are focusing on how we can specifically target ...